![]() |
市場調查報告書
商品編碼
1920926
2025-2029年癌症治療技術領域的成長機會Growth Opportunities in Cancer Treatment Technologies, 2025-2029 |
||||||
放射線治療和非放射線治療推動癌症治療的變革性發展
癌症治療技術在透過放射線治療和非放射線治療有效清除癌性腫瘤方面發揮著至關重要的作用。這些治療方法提供高度局部、微創/非侵入性和個人化的治療方案,有助於有效清除腫瘤。
全球癌症病例日益增多(主要原因是人們對癌症的認知不斷提高,以及能夠更早診斷的解決方案的出現),這正在加速這些技術的大規模應用。
醫療機構選擇這些治療方法是因為它們能夠在有效切除腫瘤的同時保護健康組織,從而改善患者的治療效果。
Frost & Sullivan的這項研究將癌症治療技術分為「放射線治療」和「非放射線治療」。放射線治療透過電離能破壞癌細胞的DNA來發揮作用,而非放射線治療則無需電離輻射即可殺死癌細胞。放射線治療包括生物導引放射線治療、近距離放射、自適應放射線治療、電子近距離放射療法和表淺放射線治療。非放射線治療包括組織溶解療法(聚焦超音波)、微波消融、水磨術、水熱蒸氣療法和用於腫瘤治療的電磁場療法。
Radiation and Non-radiation Therapies to Drive Transformational Growth in Cancer Management
Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.
The growing burden of cancer cases globally-primarily driven by increased awareness about the condition and the availability of solutions enabling early diagnosis-is accelerating large-scale adoption of these technologies.
Healthcare providers are opting for these therapies because they facilitate effective tumor removal while sparing healthy tissues, thereby improving patient outcomes.
This Frost & Sullivan research study categorizes cancer treatment technologies into radiation therapies, which work by delivering ionizing energy to damage the DNA of cancer cells, and non-radiation therapies, which kill cancer cells without ionizing radiation. Radiation therapy includes biology-guided radiotherapy, brachytherapy, adaptive radiation therapy, electronic brachytherapy, and superficial radiation therapy. Non-radiation therapy includes histotripsy (focused ultrasound), microwave ablation, aquablation, thermal water vapor therapy, and tumor treating fields.